Skip to main content
IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
2.080
+0.050 (2.46%)
Dec 20, 2024, 4:00 PM EST - Market closed

IM Cannabis Revenue

IM Cannabis had revenue of 13.88M CAD in the quarter ending September 30, 2024, with 12.23% growth. This brings the company's revenue in the last twelve months to 51.39M, down -2.23% year-over-year. In the year 2023, IM Cannabis had annual revenue of 48.80M, down -10.18%.

Revenue (ttm)
51.39M CAD
Revenue Growth
-2.23%
P/S Ratio
n/a
Revenue / Employee
540,989 CAD
Employees
95
Market Cap
5.69M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.80M-5.53M-10.18%
Dec 31, 202254.34M20.28M59.56%
Dec 31, 202134.05M18.16M114.30%
Dec 31, 202015.89M6.82M75.12%
Dec 31, 20199.07M3.88M74.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sunshine Biopharma 32.96M
Plus Therapeutics 5.73M
Tenon Medical 3.32M
Intelligent Bio Solutions 3.19M
Syros Pharmaceuticals 386.00K
Organovo Holdings 103.00K
Revenue Rankings

IMCC News

More News